JP2022546539A5 - - Google Patents
Info
- Publication number
- JP2022546539A5 JP2022546539A5 JP2022514014A JP2022514014A JP2022546539A5 JP 2022546539 A5 JP2022546539 A5 JP 2022546539A5 JP 2022514014 A JP2022514014 A JP 2022514014A JP 2022514014 A JP2022514014 A JP 2022514014A JP 2022546539 A5 JP2022546539 A5 JP 2022546539A5
- Authority
- JP
- Japan
- Prior art keywords
- myxv
- myxoma virus
- activity
- protein
- reduce
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962894925P | 2019-09-02 | 2019-09-02 | |
| US62/894,925 | 2019-09-02 | ||
| US201962944233P | 2019-12-05 | 2019-12-05 | |
| US62/944,233 | 2019-12-05 | ||
| PCT/US2020/049061 WO2021046125A1 (en) | 2019-09-02 | 2020-09-02 | A new oncolytic virus platform to treat cancers with myxoma virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022546539A JP2022546539A (ja) | 2022-11-04 |
| JP2022546539A5 true JP2022546539A5 (cg-RX-API-DMAC7.html) | 2023-09-08 |
Family
ID=74681244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514014A Pending JP2022546539A (ja) | 2019-09-02 | 2020-09-02 | 粘液腫ウイルスを用いて癌を治療するための新しい腫瘍崩壊ウイルスプラットフォーム |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11117934B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4025228A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022546539A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220112241A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114615988A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020342510A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3152779A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL291009A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022002547A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202122411A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021046125A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202100305SA (en) | 2018-07-13 | 2021-02-25 | Univ Arizona State | Methods of treating cancer with tnf expressing myxoma virus |
| CA3112788A1 (en) * | 2018-09-05 | 2020-03-12 | Arizona Board Of Regents On Behalf Of Arizona State University | Oncolytic virus platform to treat hematological cancer |
| EP3946373A4 (en) * | 2019-03-28 | 2023-01-11 | Arizona Board of Regents, a Body Corporate of the State of Arizona, acting for and on behalf of Arizona State University | FAST-PP14-EXPRESSING ONCOLYTIC MYXOMAVIRUS FOR TREATMENT OF BLOOD CANCER |
| CN114615988A (zh) | 2019-09-02 | 2022-06-10 | 亚利桑那州立大学董事会 | 用黏液瘤病毒治疗癌症的新型溶瘤病毒平台 |
| WO2022067038A1 (en) * | 2020-09-25 | 2022-03-31 | President And Fellows Of Harvard College | Immunotherapeutic virus for the treatment of cancer |
| JP2024508920A (ja) * | 2021-03-01 | 2024-02-28 | オンコミクス セラピューティクス,インク. | 多武装の粘液腫ウイルス |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2153284B1 (es) * | 1998-06-10 | 2001-09-01 | Fundacion Para El Estudio Y De | Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos. |
| KR100747646B1 (ko) | 2005-02-25 | 2007-08-08 | 연세대학교 산학협력단 | 데코린 유전자를 포함하는 유전자 전달 시스템 및 이를 포함하는 약제학적 항종양 조성물 |
| WO2007143545A2 (en) * | 2006-06-01 | 2007-12-13 | Robarts Research Institute | Tnf signaling in myxoma virus treatments |
| US8765462B2 (en) | 2007-05-04 | 2014-07-01 | University Health Network | IL-12 immunotherapy for cancer |
| FR2946536B1 (fr) * | 2009-06-11 | 2011-07-29 | Agronomique Inst Nat Rech | Utilisation d'une souche attenuee de myxoma virus comme oncolytique |
| WO2011156273A1 (en) * | 2010-06-06 | 2011-12-15 | Mount Sinai School Of Medicine | Recombinant rna viruses and uses thereof |
| EP2697368B1 (en) * | 2011-04-15 | 2019-06-05 | Genelux Corporation | Clonal strains of attenuated vaccinia viruses and methods of use thereof |
| EP2717887B1 (en) | 2011-06-09 | 2017-12-27 | University of Florida Research Foundation, Inc. | Methods for treating or preventing graft versus host disease |
| ES2895977T3 (es) | 2013-11-28 | 2022-02-23 | Bavarian Nordic As | Composiciones y métodos de inducción de una respuesta inmunitaria mejorada usando vectores de poxvirus |
| KR20160140075A (ko) | 2015-05-29 | 2016-12-07 | 코오롱생명과학 주식회사 | 폭스바이러스 유래 프로모터 및 이를 포함하는 벡터 |
| AU2016313969B2 (en) * | 2015-06-19 | 2021-12-23 | Sillajen, Inc. | Compositions and methods for viral embolization |
| WO2017123675A1 (en) | 2016-01-11 | 2017-07-20 | Synlogic, Inc. | Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells |
| CN110050062A (zh) * | 2016-08-09 | 2019-07-23 | 阿尔莫哈纳德·阿尔卡亚尔 | 表达il12的溶瘤弹状病毒 |
| WO2018156106A1 (en) | 2017-02-22 | 2018-08-30 | Ding Enyu | An mrna cancer vaccine encoding human gm-csf fused to multiple tandem epitopes |
| SG11202100305SA (en) | 2018-07-13 | 2021-02-25 | Univ Arizona State | Methods of treating cancer with tnf expressing myxoma virus |
| WO2020033510A1 (en) | 2018-08-08 | 2020-02-13 | Arizona Board Of Regents On Behalf Of Arizona State University | Method for improved poxvirus yields |
| BR112021002639A2 (pt) | 2018-08-16 | 2021-05-11 | Musc Foundation For Research Development | vírus recombinantes do mixoma e usos dos mesmos |
| CA3112788A1 (en) | 2018-09-05 | 2020-03-12 | Arizona Board Of Regents On Behalf Of Arizona State University | Oncolytic virus platform to treat hematological cancer |
| EP3946373A4 (en) | 2019-03-28 | 2023-01-11 | Arizona Board of Regents, a Body Corporate of the State of Arizona, acting for and on behalf of Arizona State University | FAST-PP14-EXPRESSING ONCOLYTIC MYXOMAVIRUS FOR TREATMENT OF BLOOD CANCER |
| CN114615988A (zh) | 2019-09-02 | 2022-06-10 | 亚利桑那州立大学董事会 | 用黏液瘤病毒治疗癌症的新型溶瘤病毒平台 |
| CA3152787A1 (en) | 2019-09-02 | 2021-03-11 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods and compositions for improving oncolytic virus infection for nonpermissive cancers |
| JP2024508920A (ja) | 2021-03-01 | 2024-02-28 | オンコミクス セラピューティクス,インク. | 多武装の粘液腫ウイルス |
-
2020
- 2020-09-02 CN CN202080076788.8A patent/CN114615988A/zh active Pending
- 2020-09-02 JP JP2022514014A patent/JP2022546539A/ja active Pending
- 2020-09-02 MX MX2022002547A patent/MX2022002547A/es unknown
- 2020-09-02 US US17/010,711 patent/US11117934B2/en active Active
- 2020-09-02 EP EP20861091.5A patent/EP4025228A4/en active Pending
- 2020-09-02 AU AU2020342510A patent/AU2020342510A1/en not_active Abandoned
- 2020-09-02 TW TW109130086A patent/TW202122411A/zh unknown
- 2020-09-02 WO PCT/US2020/049061 patent/WO2021046125A1/en not_active Ceased
- 2020-09-02 CA CA3152779A patent/CA3152779A1/en active Pending
- 2020-09-02 KR KR1020227010537A patent/KR20220112241A/ko not_active Ceased
-
2021
- 2021-06-24 US US17/357,624 patent/US20210324014A1/en not_active Abandoned
-
2022
- 2022-03-01 IL IL291009A patent/IL291009A/en unknown
- 2022-08-22 US US17/893,052 patent/US12331079B2/en active Active